Neuropathy Action Foundation Releases White Paper Urging for Action to Improve Access to Lifesaving Plasma-Derived Medicines
<p>SANTA ANA, Calif., Nov. 17, 2026 /PRNewswire/ -- Today, the Neuropathy Action Foundation (NAF) released, "Improving Access to Plasma-Derived Therapies for Neuropathy," a new white paper identifying outdated state regulations, plasma supply challenges, and insurance restrictions that can...</p>
Read original article ↗
Related Articles
China's offshore Nvidia GPU rentals face a new US licensing test
The US Commerce Department's Bureau of Industry and Security (BIS) issued an interim final rule on November 16 extending